CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Glenmark Pharmaceuticals Inc., USA recalls Theophylline (Anhydrous)…

Glenmark Pharmaceuticals Inc., USA recalls Theophylline (Anhydrous) Extended-Release Tablets

Read the official FDA notice

Published
4 Jun 2025
Units affected
8,520 100-count bottles
Agency
FDA
Country
United States

The hazard

OOS results reported for the Dissolution (by UV) test.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Theophylline (Anhydrous) Extended-Release Tablets, 600 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited. Colvale-Bardez, Goa - 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430. NDC: 68462-356-01

Brand / company
Glenmark Pharmaceuticals Inc., USA
Codes / lots
Lots: 19234121, 19234148, Exp Sep-30-25; Lots 19242881, 19242899, Exp Jun-30-26
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 4 Jun 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.